Merck has inked pacts with multiple Indian companies: Cipla, Dr Reddy's Laboratories, Sun Pharma, Hetero Labs, and Emcure Pharmaceuticals to license and produce a forthcoming treatment for Covid-19. The company, formally known as MSD, is in the process of developing molnupiravir in collaboration with Ridgeback Biotherapeutics. The investigational oral antiviral...